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Abstract
Purpose: To investigate the expression of nitric oxide synthase (NOS) and apoptosis associated 
with ischemic preconditioning (IPC) and pentoxifylline (PTX) in intestinal ischemia (I) and 
reperfusion (R) injury. 
Methods: Thirty male rats were assigned to 5 groups: (CG), no clamping of the superior 
mesenteric artery (90 minutes); (IR-SS) saline + ischemia (30 minutes) + reperfusion (60 
minutes); (IR-PTX) PTX + ischemia (30 minutes) + reperfusion (60 minutes); (IPC-IR-SS) 5 
minutes of ischemia + 5 minutes of reperfusion (IPC) + saline + I(30 minutes)+R(60 minutes); 
and (IPC-IR-PTX) IPC + PTX + I(30 minutes)+ R(60 minutes). 
Results: The application of IPC and PTX showed a significantly lower immunohistochemistry 
reaction for active caspase-3 (P<0.05) compared to IR+SS. The number of cells immunoreactive 
to BCL-2 was higher in the IR-PTX group (P>0.05). The NOS-2 expression (qRTPCR) in the IR-
PTX group (P<0.05) was higher than the values for the IPC+IR-SS and IPC-IR-PTX groups. The 
NOS-3 expression was significantly upper in the IPC-IR-PTX group than in the CG (P<0.05), the 
IR-SS (P<0.05) and the IR-PTX (P<0.05) groups. 
Conclusions: The BCL-2 and active caspase-3 showed beneficial effects on PTX and IPC. The 
expression of NOS-2 and NOS-3 in the IPC and IPC-PTX groups showed no synergistic effect.
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Oxide Synthase. Apoptosis. Rats. 
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 Several reports have described 
the effects of IPC on the reduction of 
apoptosis of epithelial cells3,6,14,15, structural 
protection3,7,9,12,14,15, preservation of intestinal 
contractility12, decreased expression of the 
transcription factor nuclear-kB (NF-kB), cell 
adhesion molecules and pro-inflammatory 
cytokines3,7,15,16, diminution of the inflammatory 
infiltrate3,7,13-16, and increased synthesis of 
nitric oxide (NO)11,14. NO synthesis derived 
from IPC has been associated with tissue 
protection6,5,9,11,14. However, the mechanisms 
by which IPC protects the intestine following IR 
are still not fully understood.
 In addition to IPC, the use of drugs 
such as pentoxifylline (PTX), a methylxanthine 
derivative of theobromine, has been 
proposed to decrease the deleterious effects 
of IR3,8,17-23. Protective effects of PTX include 
the anti-inflammatory actions associated 
with inhibition of NF-kB activity19-22, down-
regulation of interleukin (IL)-6, tumor 
necrosis factor (TNF)-alpha synthesis, and 
decreased apoptosis8,19-23 and inhibition of 
NO production by inflammatory signaling17-23. 
The activity of unspecific phosphodiesterase, 
an antioxidant, increases intracellular 
cyclic adenosine monophosphate (cAMP) 
concentrations, and it has been previously 
used to treat peripheral vascular disease and 
intermittent claudication17,18,21. However, the 
pharmacological properties of PTX are not fully 
understood. 
 Clinical biomarkers are used to diagnose 
the conditions of the development or inhibition 
of apoptosis and the deleterious effects 
of ischemia and reperfusion. BCL-2 (B-cell 
lymphoma 2), is a protein encoded in humans 
by the Bcl-2 gene and is specifically considered 
an important anti-apoptotic protein. Localized 
in the outer membrane of mitochondria, it 
plays a crucial role in promoting cellular survival 
and inhibiting the actions of pro-apoptotic 
proteins13,15,23. 
 ■ Introduction 
 Intestinal ischemia–reperfusion injury 
(IR) is a frequent phenomenon with high 
morbidity and mortality. It is associated with 
a number of clinical conditions, including 
abdominal aortic aneurysm, surgery, 
cardiopulmonary bypass, strangulated hernias, 
intestinal obstruction, acute mesenteric 
ischemia, necrotizing colitis, collapse of 
systemic circulation (hypovolemic and septic 
shock), and intestinal transplantation1-3. 
 Interruption of blood supply to the 
intestine could result in tissue damage. 
However, the subsequent blood flow 
restoration may lead to additional injury, 
referred to as reperfusion injury1-5. 
 Although intestinal IR induced 
inflammation has been studied extensively 
in animal models and in humans, the 
induced inflammatory responses have yet 
to be characterized1,4-9. There is abundant 
information on the compromising effects of 
IR on many processes in the intestine, and 
various protective treatment modalities 
have successfully been applied to mitigate 
reperfusion injury in animal models of 
reperfusion injury of the intestine, such as 
pharmacologic treatment, chemical agents, 
and ischemic preconditioning3,4,6-12. 
 Among the available strategies is 
ischemic preconditioning; since its introduction 
more than thirty years ago in cardiac 
surgery9,10, ischemic preconditioning has 
demonstrated favorable effects in numerous 
other clinical situations or with experimental 
animals in different organs and tissues or 
in shock by retarding cell death3,4,6,7,9-16. 
Ischemic preconditioning can be mechanical 
or pharmacological3,4,6,8,9,11. Direct mechanical 
preconditioning in which the target organ is 
exposed to brief ischemia prior to prolonged 
ischemia has the benefit of reducing ischemia-
reperfusion injury3,6,7,9-16. 
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 On the other hand, caspase is a 
cysteine protease, and cleaved caspase-3, the 
active form of caspase-3, is well known as a 
marker for cells undergoing apoptosis; it is 
now widely accepted that cleaved caspase-3 
staining is useful in scoring the apoptotic 
index13,15,23,24. Studies in direct IPC have 
demonstrated the protective effect of NO on 
microcirculation2,9,10,14,15,17.  NO is a free radical 
produced from L-arginine by the enzyme NO 
synthase, which has three forms: endogenous 
NOS (NOS-3), neuronal NOS (NOS-1), and 
inducible NOS (NOS-2)3,5. Of these, NOS-3 
and NOS-1 are constitutively expressed, while 
NOS-2 is produced in response to cytokines 
and NF-kB. NOS-3 has a protective effect on 
the microcirculation and always produces NO 
in small amounts, which predominate in the 
circulation, producing a protective effect on 
the microcirculation that is of vital significance 
to the blood flow to the organs5,9-11,17,18,25.
 Histological evaluation in our previous 
publication showed a favorable effect in the 
IPC-IR-SS and IPC-IR-PTX groups, which is in 
accordance with the hypothesis of a beneficial 
effect of IPC alone or PTX; however, the 
simultaneous action of both did not provide 
better protection26. Based on the common 
assumption that IR injury can go through 
distinct biomolecular pathways, we have 
proposed to study: (1) the immunochemistry 
expression of active caspase-3 and BCL-2 under 
the simultaneous action of IPC and PTX, which 
separately have a favorable effect on intestinal 
IR damages; and (2) the participation of NOS-
2 and NOS-3 in the protective effects of IPC 
and PTX submitted to intestinal IR in rats, with 
the mRNA expression levels determined from 
epithelial cells.
 ■ Methods
 All animal experiments were carried out 
in accordance with the recommendations of 
international legislation on animal protection. 
The Ethics Committee in Research of the 
Universidade Federal de São Paulo (UNIFESP) 
approved the study. 
 Thirty male Wistar-EPM-1 rats (250-
300g) were purchased from the Center for 
the Development of Experimental Models for 
Medicine and Biology (CEDEME, Sao Paulo-
SP, Brazil). The animals were housed under 
controlled temperature (23℃), 50% air humidity 
and light conditions with a 12-hour light/
dark cycle. The rats had free access to water 
and standard pellet chow until 6 hours before 
the surgical procedures at the Experimental 
Surgery Department of UNIFESP. The individual 
cages had dimensions of 40 cm × 30 cm × 25 
cm and, which were covered with previously 
autoclaved wood shavings. 
 All procedures involving anaesthesia 
and euthanasia were performed according to 
followed the guidelines of the National Council 
Animal Experimentation Control (SBCAL/
COBEA – Brazil http://www.cobea.org.br/). 
 The surgical procedures were 
performed under intramuscular anesthesia 
with 80 mg/kg of ketamine (Dopalen® 80 mg/kg, 
Sespo Indústria Comércio, Paulínea-SP) and 10 
mg/kg of xylazine (Dopaser® 5 mg/kg, Herpate 
Callieri, Juatuba-MG). The femoral vein was 
dissected and catheterized for drug infusion 
of 80 mg/kg pentoxifylline (Sigma Aldrich, São 
Paulo-SP) or 0.9% saline solution in the control 
group 5 minutes before ischemia. A median 
abdominal incision was made to identify the 
superior mesenteric vessels and clamping was 
done according to the group. The animals were 
randomly assigned into five groups:
 CG - Control group: anesthesia + 
laparotomy + no clamping of the superior 
mesenteric artery (timing elapsed 90 minutes). 
 IR-SS group: saline + 30 minutes of 
ischemia + 60 minutes of reperfusion. 
 IR-PTX group: pentoxifylline + 
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30 minutes of ischemia + 60 minutes of 
reperfusion.
 IPC-IR-SS group: five minutes of 
ischemia + five minutes of reperfusion 
(preconditioning) + saline + 30 minutes of 
ischemia + 60 minutes of reperfusion. 
 IPC–IR-PTX group, five minutes 
of ischemia + five minutes of reperfusion 
(preconditioning) + pentoxifylline + 30 minutes 
of ischemia + 60 minutes of reperfusion.
 At the end of reperfusion, two samples 
of jejunal segments (3 cm long) were opened 
longitudinally, gently washed with saline 
solution, and one of them was wrapped in 
aluminum foil and frozen in liquid nitrogen. 
The other one was fixed in 10% formaldehyde 
phosphate buffered solution.
Immunohistochemistry (IHC) analysis 
 IHC is a commonly used technique to 
monitor protein expression and localization 
in the context of tissue morphology. Tissue 
samples were fixed in 10% neutral buffered 
formaldehyde, embedded in paraffin wax, 
cut into thin slices (3 µm) and mounted onto 
silanized slides. The sample was deparaffinized 
and hydrated. Assay procedures were 
performed according to the manufacturer’s 
instructions. The epitopes were blocked with 
peroxidase and incubated with a specific first 
antibody. The primary antibody to verify cell 
apoptosis was assessed using an anti-active 
caspase-3 antibody, diluted to 1:200 (rabbit 
heterologous polyclonal antibody ABCAM-
AB2302, São Paulo-SP). The anti-apoptotic 
analysis was done using a primary antibody 
anti-BCL-2, diluted 1:100 (monoclonal mouse 
antibody, DAKO, M00884, São Paulo-SP). 
The sections were washed with PBS solution 
and incubated with biotinylated secondary 
antibody, avidin-chain enzyme, stained 
with DAB, and lastly with hematoxylin. The 
sections were dehydrated conventionally with 
ethanol, cleared with xylene, and mounted 
with synthetic resin. A scanner (3D HISTECH®, 
Biogen, São Paulo-SP) captured all images of 
the immunohistochemistry slides. The images 
were analyzed by specific software Case 
Viewer® (3D HISTECH®, Biogen, São Paulo-SP; 
magnification x20, x40, x50). A perimeter of 
1.000 microns was determined on each slide. 
Within the perimeter, ten villi were randomly 
selected, and 100 epithelial cells were counted 
in 10 villi per slice for 5 treatment groups 
(each group, N=6), determining the score 
of immunohistochemically stained cells 60 
villi or 10 villi per slice in 6 groups for each 
treatment. The data were expressed as mean 
± standard error of the mean (x ± sem). The 
difference between the groups was processed 
by repeated measures analysis of variance and 
the Bonferroni post hoc comparison test. The 
results were processed by statistical software 
Stat Plus the Analyst Soft Inc® (version 9.4). 
The analysis of mRNA NOS-2 and NOS-3 
expression by qRT-PCR  
	 After the storage period, all the 
tissue samples were prepared for qRT-PCR 
(LifeTechnologies™, Grand Island, NY, USA) 
for NOS-2(iNOS) and NOS-3(eNOS). Initially, 
for total RNA extraction, the tissue segment 
was lysed in Trizol (Trizol, Invitrogen™) and 
homogenized into the extractor (Polytron 
3000). Purelink™ RNA Mini Kit and treatment 
Pure Link DNAse™ were used to achieve 
purification of the total RNA. The samples 
were subjected to electrophoresis on 1% 
agarose gel and reading by Spectrophotometer 
(NanodroP®) to assess the purity of the samples 
and their RNA concentrations (µg/mL), 
respectively. In the reverse transcription of 
total RNA, for the synthesis of the primary band 
of complementary DNA or cDNA, SuperScript™ 
Vilo™ Master Mix (Life Technologies™ - USA) 
and Reverse Transcriptase were used, and 
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the sample was submitted to a GeneAmp 
2700 thermocycler (Perkin-Elmer, Inc., 
Waltham, MA, USA) at 25°C temperature for 
10 minutes, 42°C for 60 minutes and at 85°C 
for 5 minutes. The qRT-PCR reaction occurred 
from a sample-diluted cDNA and was amplified 
in 20 µL reaction volume distributed also in 
the wells. The final reaction mixture included 
the following: primers, 10 pmol; MgCl2, 2.5 
mM; Deoxyribonucleosides triphosphate 
(dNTP) mixture (included in the TaqMan Gene 
Expression Master Mix kit, Life Technology™- 
São Paulo, SP, Brazil), 1 mM; 10 × RNA PCR 
buffer, 1x; 1x ExTaq™ DNA polymerase; and 0.5 
U/ reaction of AmpliTaq Gold™ DNA Polymerase 
(included in the TaqMan Gene Expression 
Master Mix, Life Technology, São Paulo-
SP). The PCR was performed with an initial 
denaturation at 95°C for 10 minutes, 40 cycles 
at 95°C for 15 seconds and 60°C for one minute. 
Glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH; TaqMan™ Endogenous Control, 
Invitrogen™ Rn01775763_g1) was used as a 
“housekeeping gene” (internal control gene) 
to indicate the amount of cDNA in the sample 
reference control and the experimental sample 
in PCR. The target genes were NOS-2 (iNOS) 
(TaqMan gene expression assay, Invitrogen/ 
Rn00561646_m1) and NOS-3 (eNOS) 
(TaqMan gene expression assay, Invitrogen/
Rn02132634_s1). The samples were performed 
in triplicate. The products were amplified 
by Step One Plus vs 2.3 software (Applied 
Biosystems™) to obtain the reading of the 
amount of amplified cDNA during the reaction. 
To calculate the mean value of the cycle 
thresholds (Ct) relative on the reference gene, 
the value was subtracted from the mean value 
of the target gene Ct. The ∆∆Ct calculation 
was converted into a linear expression from 
the logarithmic exponential function (log 2)27. 
Afterward, the results were expressed as the 
mean, standard error, 95% confidence interval, 
and an analysis of variance (ANOVA) and the 
Bonferroni post hoc test were performed to 
evaluate significant differences between the 
means of the experimental groups. The level 
of rejection of the null hypothesis was set at 
5% (p ≤ 0.05). All calculations were performed 
using Stat software version 9.4®.
 ■ Results
Immunohistochemistry analysis with anti-
active caspase-3 and anti BCL-2 
 Analysis of the cell immunoreactivity 
(Figures 1 A-E) shows the photomicrographs 
of tissues incubated with activate caspase-3 
antibody. The cells of the injured villi were 
measured, but the phagocytes were not 
measured. The average of the immunoreactive 
cells differed between the treatments (F= 
47.2, p<0.05). The average scores in the 
immunoreactive cells in the IR-SS group (64.1 
± 3.02; 95% CI 58.1-70.1) were significantly 
higher than those in the CG (3.37 ± 0.403; 95% 
CI 2.56 - 4.17), IR-PTX (2.92 ± 0.488; 95% CI 
1.94-3.89), IPC-IR-SS (0.72 ± 0.128; 95% CI 0.46 
- 0.973), and IPC-IR-PTX (2.82 ± 0.373; 95% CI 
2.07-3.56) groups. There was no significant 
difference among treatments for the other 
comparisons (Figure 2).
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Figure 1 - Photomicrography the histological sections of intestines of rats subjected to active caspase-3 
immunostaining and counterstained with hematoxylin. Note the higher immunoreactivity (arrows) in the 
intestinal villi of the IR-SS group (B). Few active caspase-3-positive cells (arrows) can also be noticed in the CG 
(A), IR-PTX (C), IPC-IR-SS (D) and IPC-IR-IPTX (E) groups. Scale bare: 50 µm.  
Figure 2 - The expression of active caspase-3 was analyzed, and the difference was determined between 
groups for the model of repeated measures analysis of variance. (*) The difference was analyzed by pairs; 
statistically significant values are represented in the chart.
 Figures 3A-E show the tissues of rats 
intestine incubated with BCL-2 antibody. The 
epithelial stain cells were measured, and the 
average analysis of the immunoreactive cells 
differed between the treatments (F = 4.96; 
P = 0.0015). The immunoreactive cells in the 
IR-PTX group (10.5 ± 0.795; 95% CI 0.832 - 
1.1) were significantly higher than those in 
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the IR-SS (5.05 ± 0.569; 95% CI 1.35 - 1.61), 
IPC-IR-SS (2.47 ± 0.372; 95% CI 0.828 - 1.04), 
and IPC-IR-PTX (2 ± 0.29; 95% CI 0.736-0.93) 
groups, whereas the averages in the IPC-IR-SS 
group were significantly lower than those in 
the CG group (7.95 ± 0.78; 95% CI 0.931-1.24). 
There was no significant difference between 
treatments for the other comparisons (Figure 4).
Figure 3 – The photomicrographs of histological sections of rats intestines subjected to BCL-2 immunostaining 
and counterstained with hematoxylin.  Note the higher presence of immunostained epithelial cells (arrows) 
in the intestinal villi of the CG (A) and IR-PTX (C) groups. Few immunostained epithelial cells (arrows) can also 
be observed in the IR-SS (B), IPC-IR-SS (D) and IPC-IR-IPTX (E) groups. Scale bare: 50 µm.  
Figure 4 – The expression of BCL-2 was analyzed, and the difference was determined between groups for 
the model of repeated measures analysis of variance. (*) Differences were analyzed by pairs. Statistically 
significant values are represented in the graphic.
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Evaluated mRNA expression of NOS-2 and 
NOS-3 by qRT-PCR
 The average analysis of expression 
of NOS-2 differed between the treatments 
(ANOVA, F= 8.11, P=0.0002). The IR-SS group 
exhibited a significant increase in NOS-2 
expression (6.01± 1.34; 95% CI: 2.56 - 9.47). The 
NOS-2 level in the control group (1.38±0.52; 
95% CI: 0.04 - 2.72) was lower than the level in 
the IR-SS group. The IR-PTX (2.27±1.28; 95% CI: 
-1.02 - 5.57) and IPC-IR-SS (0.23±0.10; 95% CI: 
0.006 - 0.13) groups significantly reduced NOS-
2 expression in comparison to the IR-SS group. 
The combination of procedures in the IPC-IR-
PTX group (0.04±0.01; 95% CI: 0.006 - 0.08) 
drastically reduced NOS-2 expression (Figure 5). 
Figure 5 - Data from mRNA expression of NOS-2 by qRT-PCR. Differences among groups were analyzed by 
ANOVA followed by the Bonferroni test. (*) The differences were analyzed by pairs. Statistically significant 
values are represented in the graphic.
 Our results showed that a significant 
difference between analysis of average of 
NOS-3 expressions in the treatments (ANOVA, 
F= 5.47, P=0.0027). The NOS-3 expression 
levels were also increased in the IPC-IR-SS 
group (1.61±0.11; 95% CI 1.32 - 1.89), IR-SS 
(1.24±0.16; 95% CI 0.83-1.65) and the IR-
PTX group (1.29±0.08; 95% CI 1.08 - 1.49), 
but these levels were not significantly higher 
than the levels observed in the control group 
(1.10±0.20; 95% CI: 0.58 - 1.61). However, 
NOS-3 expression was significantly increased in 
the IPC-IR-PTX group (1.95±0.15; 95% CI: 1.55 
- 2.35) compared with the groups CG, IR-SS, IR-
PTX (Figure 6).
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Figure 6 – Data from mRNA expression of NOS-3 by qRT-PCR. Differences among groups were analyzed by 
ANOVA followed by the Bonferroni test. (*) The differences were analyzed by pairs. Statistically significant 
values are represented in the graphic.
 ■ Discussion 
 With the intent of studying the effects 
of intestinal ischemia, we have used an animal 
model in rats that have been subjected to 30 
minutes of intestinal ischemia and 60 minutes 
of reperfusion (IR). We have investigated 
the effects of pentoxifylline (PTX - 80 mg/kg) 
applied (IV) before the onset of ischemia and/
or ischemic preconditioning (IPC).
 This study demonstrates that PTX (80 
mg/kg) or IPC can protect against intestinal 
apoptosis in rats. The immunoreactivity is 
minimal to active caspase-3 and present to 
BCL-2 in the mechanic and pharmacology 
preconditioning. However, the combination 
of both did not show an adjuvant effect. In a 
study of pro-apoptotic genes, the caspase-3 
expression was higher in tissues subjected to 
IR23 and lower in tissues subjected to IPC-IR13,15. 
It has been shown that the use of pretreatment 
with pentoxifylline attuned the expression of 
active caspase-323 and decreased caspase-3/9 
and the c-Jun N-terminal kinase (JNK) signaling 
pathway8.
 In intestinal IR, we observed a 
significant difference in the BCL-2 expression 
with treatment of IR-PTX compared with 
the CG, IR and IPC groups. Furthermore, if 
pentoxifylline could suppress caspase-3/9 and 
JNK8, this could be interpreted as a significant 
difference between the anti-apoptotic agents 
(BCL-2) in this group. In addition, in IPC in the 
experimental study in the intestine, it could 
be suggested that the lower stimulation of the 
apoptotic protein caspase-36,13 would be able 
maintain the necessary level of BLC-23,4,6,13. 
It provide protections: blocking oxidative 
damage to cell components and influencing cell 
membrane transport, altering the distribution 
of calcium, inhibiting release of cytochrome C 
from the mitochondria to the cytoplasm and 
protecting DNA fragmentation13.
 The cell death pathways, such as necrosis, 
autophagy, the death receptor apoptotic 
pathway, post-ischemic inflammation and 
necroptosis, are operating simultaneously2,5. All 
these pathways could get activated at different 
times and in certain time gaps. The therapy for 
prevention of IR, for example, could depend 
on the mitochondrial apoptotic pathway alone 
or assessment at a particular time point, or 
the therapy could release other endogenous 
substances at the plasma membrane or the 
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cytoplasmic pathways, for instance, anion 
channel, BCL-2 family proteins and JNK, among 
others molecular pathways2,5,9,28. 
 After IR in the current molecular study, 
a significant increase in the expression of NOS-
2 was observed. The expression of nitric oxide 
synthase (NOS-2 and NOS-3) was evaluated, 
and the results showed that the mean NOS-
2 expression in the ischemia and reperfusion 
group was higher than that for the control 
group; we also found that the PTX produced 
a significant reduction of NOS-2. On the other 
hand, the reduction promoted by IPC, alone or 
in association with PTX, was intense and almost 
neutralized the expression of the NOS-2. The 
NOS-2 enzyme is regulated at the transcriptional 
level, and its activation is independent of 
the intracellular calcium concentration2,5,25. 
Experimental research related the anti-
inflammatory effect and involvement in the 
control of NOS-28,9,15 and NOS-328 for the action 
of PTX17-23 and IPC 3,4,7,9,11,14-16,25,30. High NO levels 
associated with inflammatory conditions and 
activation of NOS-2 have been related to tissue 
injury3,4,5,9,25.
 The synthesis of NO by NOS-2 and NOS-
3 depends on the induction mechanism, half-
life, and the period of stimulation28. NO in such 
conditions may promote tissue damage or 
beneficial effects2,4,5,9,11,14,15,25,28. Analyses of the 
expression levels of 84 genes encoding proteins 
that are associated with oxidative stress during 
120 minutes of IR in mouse intestine indicated 
47 genes, including NOS-2, showed increased 
expression29. Previously, mRNA expression 
levels of NOS-2 and NOS-3 were evaluated 
during IR of the superior mesenteric artery 
(40 minutes of ischemia and 300 minutes of 
reperfusion) in the rat intestine. The observed 
effects included increased NO synthesis, 
decreased mesenteric vascular response, and 
increased production of the toxic oxidizing 
species peroxynitrite (ONOO)25. In IR, ROS such 
as O
2-
 are produced concomitantly with NOS-
2-derived NO. Both reactive species efficiently 
react, generating ONOO-, which initiates lipid 
peroxidation2-6,13,25,29. In the other direction, 
NO binds thiol groups of cysteine of proteins 
resulting in S- nitrosylation, an important cell 
signaling pathways9.        
 NO expression is also affected by 
ischemic preconditioning11, by reduction in the 
generation of pro-inflammatory cytokines and 
the preservation of blood flow, oxygenation, 
and mitochondrial function2-5,7,14. Furthermore, 
in the intestine, IPC protection has been 
associated with inhibition of NOS-2 expression 
levels4,14,25,30. A study in rat intestines indicated 
that IPC reduced the expression of leukocyte 
adhesion proteins, endothelial cell adhesion 
proteins, and the NF-κB-dependent expression 
of TNF-α15,16. Data from animal model have 
shown that IPC reduced NO levels in serum 
and lung after intestinal IR6. An investigation on 
the transcriptional activation of NOS-2 during 
hepatic hypoxia via intestinal IR found that 
NFκB activates the transcription of multiple 
inflammatory genes, including TNFα and IL1β. 
The research suggested that IPC may inhibit 
NF-κB, p65 activation and decrease liver injury 
and the infiltration of inflammatory cells13. 
Several studies described the inhibition of 
NOS-2 expression levels by IPC in heart tissue 
submitted to IR, and in these conditions, IPC 
has been associated with cardio protection9. 
These findings, as well as those of the present 
study, suggest that NOS2 levels decreased in 
IPC. 
 NOS-2 mRNA expression levels by the 
PTX group downregulated TNF-alpha8, derived 
inhibitory effects on NF-kB activity8,18-20,22,23. 
PTX is described to diminished interleukin-1 
and interleukin-617,20,21,23, increase intracellular 
levels of cAMP, and exerts its effects through 
both protein kinase A (PKA) mechanisms17-19. 
Moreover, cAMP and PKA activation have 
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been shown to inhibit signaling via the NFk-B 
pathway and decrease TNF18,19 and pro-
inflammatory cytokines21.Thus, our hypothesis 
confirms the beneficial effects listed in these 
previous findings. 
 In this study, the NOS-3 expression 
was significantly higher in the IPC-IR-PTX 
group than in the IR-PTX, IR-SS and CG groups. 
In a study of intestines submitted to IR, an 
increase in NO and a reduction in intestinal 
smooth muscle contraction and reactivity to 
vasoconstrictors was detected25. As stated 
previously, IPC reduced the generation of pro-
inflammatory cytokines, preserving blood flow, 
oxygenation, and mitochondrial function2-5,7,14, 
and it has been associated with inhibition of 
NOS-2 expression levels4,14,25,30. Preconditioning 
is triggered by an initial increase in nitric oxide 
synthesis11.
 The NOS-3 exerts a function as 
a vasodilator and an anti-inflammatory 
mediator28. The NOS-3 phosphorylation is 
regulated up and down and depends on 
the phosphorylation or dephosphorylation 
domains at each of the respective sites, 
the protein–protein interactions, and the 
bioavailability of cofactors; these can occur 
simultaneously, with all or combinations of 
these proceeding to activation. For instance: 
three domains that contain phosphorylation 
sites could be inhibiting or stimulating NOS-3; 
oxygenase, Calmodulin (CaM) and reductase 
domains. These domains modulate NOS-3 
activity and specific stimuli influence multiple 
pathways such as: AMPK phosphorylates the 
vasodilator bradykinin and the shear stress, 
resulting in decreasing NO or increasing NO 
production, according to the specific activated 
domain28. 
 Another pathway involving caveolins 
is associated with the PI3K/Akt signaling 
pathway28. The activity of NOS-3 is regulated 
by plasma membrane invaginations known 
as caveolae, which contain G protein-coupled 
receptors, heterotrimeric G proteins, tyrosine 
kinase type receptors, mitogen-activated 
protein (MAP) kinase pathway proteins, Src 
tyrosine kinases, and NOS39,28. The activation 
of NOS3 also depends on the formation of the 
Ca++/calmodulin complex using calcium from 
the endoplasmic reticulum or the extracellular 
milieu28. Nitric oxide elevation could be from 
diffusion into the adjacent cell on the smooth 
muscle of the intestinal vessels and exerting 
control over the vascular tone25,28.  NO inhibits 
the adhesion of platelets and leukocytes 
to endothelial cells and decreases platelet 
aggregation; it also participates in the control of 
the release of a plasminogen-activating factor 
and its inhibitor, PAI-1, thereby improving 
hemodynamics17,25.
 The importance of higher concentrations 
of pentoxifylline has been highlighted. The PTX, 
as a non-selective phosphodiesterase inhibitor, 
was associated with increases in cAMP levels17-19 
and an amplified signaling pathway17-19. One of 
the PI3K/Akt signaling pathways that actives 
the cyclic guanosine monophosphate (cGMP), 
when in smooth muscle cells constituent of 
endothelium vessels, raises resistance vessels, 
which include NOS-3 expression activated via 
sensitivity to shear stress or other stimuli28. 
The effects that increase vasodilation, as well 
a consequence of decreases in leukocyte 
adhesion, increase erythrocyte flexibility17,28 
and act in the signaling pathways involved in 
the synthesis of NF-κB expression8,18-20,22,23. 
 The lack of consensus on research 
protocols related to the best IR duration limits 
the comparison of our results with those of 
other studies.
 Future studies of IPC and pentoxifylline 
may focus on other pathways besides the 
apoptosis inhibition pathways, such as 
molecular pathways associated with cGMP and 
cAMP in IR with the ambivalent effect of NO on 
these pathways. Besides that NF-κB modulation 
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was including the phosphatidylinositol 3 kinase 
(PI3K/Akt) pathway. 
 The results of previous studies and this 
study indicate that pentoxifylline17-23,26 and 
IPC3,4,7,9,11,14-16,25,26,30 have robust protective effects 
in the intestine of rats subjected to IR. For this 
reason, pentoxifylline has anti-inflammatory 
activity, increases vascular resistance and 
improves erythrocyte flexibility; this drug can 
be used in some clinical conditions, including 
during an acute deficiency in the blood supply 
and for the attenuation of the adverse effects 
of organ and tissue transplantation. 
 The data on the integrity of the rat 
jejunum mucosa26, control the apoptosis and 
modulation of NOS are relevant to future study 
of the signaling pathway control of nitric oxide 
and nitrosylation.
 ■ Conclusions
 The IPC and pentoxifylline alone: 
decrease NOS-2 expression, a compensatory 
up-regulation of NOS-3 expression and 
control the apoptosis after intestinal IR injury. 
When viewed the IPC-PTX and IPC groups, no 
synergism effects was observed.
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